Comparison of the SureX® HPV genotyping test with the Digene Hybrid Capture® 2 test in cervical cancer screening
IntroductionCervical cancer, predominantly caused by high-risk human papillomavirus (HR-HPV) infections, is a critical public health issue. Effective screening is essential. This study compares the SureX® HPV genotyping test, which detects 25 HPV types, with the widely used Digene Hybrid Capture® 2...
Tallennettuna:
| Päätekijät: | , , , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artikkeli |
| Kieli: | englanti |
| Julkaistu: |
Frontiers Media S.A.
2025-07-01
|
| Sarja: | Frontiers in Oncology |
| Aiheet: | |
| Linkit: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1627935/full |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|